OncoMatch/Clinical Trials/NCT07778173
Three-Dimensional Molds Based on Radiological imagEs in Patients With Cancer: the DIRECT Trial
Is NCT07778173 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for cancer.
Determination of the sites from which the histopathological samples in surgically removed lesions are collected is still done by eye by a pathologist. As radiological determination of regions of interest has already proven useful in in vivo use cases, the implementation of sampling of ex vivo lesions with the help of radiological imaging suggests great potential. By developing and implementing mold printing processes, these molds have the potential to vastly improve the accuracy and consistency of histopathological sampling and collection of tissue samples from different regions of tumor, leading to improved characterization, more individualized treatments, and eventually better survival.
Check if I qualifyExtracted eligibility criteria
Cancer type
Tumor Agnostic
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07778173 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify